Showing results (1461-1470 of 3,399) with videos related to

Sort By:
Pageof 340
Neuromuscular Disorders : NMD|December 3, 2014
Implantation of a left ventricular assist device as a destination therapy in Duchenne muscular dystrophy patients with end stage cardiac failure: management and lessons learnedFrancesca Iodice, Giuseppina Testa, Marco Averardi, et al.
Neuromuscular Disorders : NMD|January 21, 2015
Inclusion body myositis and sarcoid myopathy: coincidental occurrence or associated diseasesOranee Sanmaneechai, Andrea Swenson, Alicia K Gerke, et al.
Neuromuscular Disorders : NMD|December 3, 2014
Isolated laryngeal myasthenia gravis for 26 yearsDimitri Renard, Amir Hedayat, Corinne Gagnard
Neuromuscular Disorders : NMD|December 3, 2014
Abnormal proliferation and spontaneous differentiation of myoblasts from a symptomatic female carrier of X-linked Emery-Dreifuss muscular dystrophyPeter Meinke, Peter Schneiderat, Vlastimil Srsen, et al.
Neuromuscular Disorders : NMD|December 3, 2014
Assessment of ventricular function in mouse models of muscular dystrophy: a comparison of MRI with conductance catheterAlison M Blain, Elizabeth Greally, Steven H Laval, et al.
Neuromuscular Disorders : NMD|December 30, 2014
A novel GBE1 mutation and features of polyglucosan bodies autophagy in adult polyglucosan body diseaseSimone Sampaolo, Teresa Esposito, Fernando Gianfrancesco, et al.
Neuromuscular Disorders : NMD|December 18, 2013
The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositisL N Alfano, L P Lowes, I Dvorchik, et al.
Neuromuscular Disorders : NMD|January 15, 2020
X-linked infantile spinal muscular atrophy (SMAX2) caused by novel c.1681G>A substitution in the UBA1 gene, expanding the phenotypeNiamh Shaughnessy, Eva B Forman, Declan O'Rourke, et al.
Neuromuscular Disorders : NMD|November 22, 2020
Adolph Seeligmüller's contribution to myotonia congenita ThomsenCarolin Arendt, Stephan Zierz
Neuromuscular Disorders : NMD|September 5, 2020
White matter brain lesions in infantile-onset Pompe disease are not metabolically active using 18F-FDG PET/MR imagingKristl G Claeys, Christophe E Depuydt, Stefan Sunaert, et al.
Pageof 340